Recent evidence indicates that cyclophosphamide exposure increases the risk of hematologic malignancies in patients with rheumatoid arthritis. In a large administrative database cohort of patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback